These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28121292)

  • 1. Ranpirnase eradicates human papillomavirus in cultured cells and heals anogenital warts in a Phase I study.
    Squiquera L; Taxman DJ; Brendle SA; Torres R; Sulley J; Hodge T; Christensen N; Sidransky D
    Antivir Ther; 2017; 22(3):247-255. PubMed ID: 28121292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
    Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
    Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
    Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
    BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
    Senatori R; Dionisi B; Lippa P; Inghirami P
    Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of intraurethral condylomata acuminata with surgery and cidofovir instillations in two immunocompromised patients and review of the literature.
    Florin HJ; Snoeck R; Van Cleynenbreugel B; Albersen M
    Antiviral Res; 2018 Oct; 158():238-243. PubMed ID: 30153444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of human papillomavirus types in anogenital warts of men.
    Chan PK; Luk AC; Luk TN; Lee KF; Cheung JL; Ho KM; Lo KK
    J Clin Virol; 2009 Feb; 44(2):111-4. PubMed ID: 19097933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genital warts.
    Steben M; Garland SM
    Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1063-73. PubMed ID: 25155525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU; Introcaso C; Dunne EF
    Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.
    Komloš KF; Kocjan BJ; Košorok P; Luzar B; Meglič L; Potočnik M; Hočevar-Boltežar I; Gale N; Seme K; Poljak M
    J Med Virol; 2012 Aug; 84(8):1233-41. PubMed ID: 22711351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
    Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
    Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes.
    Chu YW; Liu ST; Yang YL; Huang SM; Wang WM
    J Biomed Sci; 2017 Aug; 24(1):55. PubMed ID: 28810862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial of 1% and 5% 5-fluorouracil creams compared with 90% trichloroacetic acid solution for anogenital wart treatment.
    Anggraini I; Hoemardani AS; Nilasari H; Indriatmi W
    Int J STD AIDS; 2020 Aug; 31(9):849-858. PubMed ID: 32605501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anogenital human papilloma virus and the problem of persistence.
    Syrjänen K
    Eur J Dermatol; 1998; 8(7 Suppl):5-7; discussion 20-2. PubMed ID: 10387956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.
    Schön HJ; Grgurin M; Szekeres T; Schurz B
    Wien Klin Wochenschr; 1996; 108(2):45-7. PubMed ID: 8835432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment for human papillomavirus-associated genital warts in humans with the novel tellurium immunomodulator AS101: assessment of its safety and efficacy.
    Friedman M; Bayer I; Letko I; Duvdevani R; Zavaro-Levy O; Ron B; Albeck M; Sredni B
    Br J Dermatol; 2009 Feb; 160(2):403-8. PubMed ID: 18808418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of human papillomaviruses infection in men with genital warts in Shanghai.
    Chen X; Li L; Lai Y; Liu Q; Yan J; Tang Y
    Oncotarget; 2016 Aug; 7(33):53903-53910. PubMed ID: 27270315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genital warts in HIV-infected individuals].
    Wieland U; Kreuter A
    Hautarzt; 2017 Mar; 68(3):192-198. PubMed ID: 28160045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.